Tissue Regenix

Tissue Regenix uses its patented dCELL® technology to address many clinical needs such as sports medicine, wound care and heart valve replacement.

Founded

2006

Raised

$1.3M

Follow us

Also headquartered in New York

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Add round

02 Jan 2007

$1,349,658

Undisclosed funding